Study population [Design Issues]

posted by avrahan – 2014-10-20 17:17 (3468 d 19:05 ago) – Posting: # 13758
Views: 2,928

Dear All

I would like to perform a BE study for a drug indicated to:
  1. Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.
  2. Also indicated for use in secondary amenorrhea.
In this case should I recruit females with postmenopausal condition or no restriction should be done? :confused:

Thanks for your reply.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,662 registered users;
97 visitors (0 registered, 97 guests [including 5 identified bots]).
Forum time: 12:23 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5